M&A Deal Summary |
|
|---|---|
| Date | 2020-01-08 |
| Target | Riemser Arzneimittel AG |
| Sector | Life Science |
| Buyer(s) | Esteve Pharmaceuticals S.A. |
| Sellers(s) | Ardian |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1929 |
| Sector | Life Science |
| Employees | 2,300 |
| Revenue | 758M EUR (2018) |
Esteve Pharmaceuticals, S.A. is a global pharmaceutical company offers solutions in the pharmaceutical segment, mainly in Spain with a broad and highly innovative product portfolio and as a global Contract Manufacturing Organization (CMO). ESTEVE is at present advancing in its transformation journey to become an international proprietary specialty pharmaceutical company.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| Country: Germany M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-07-31 |
Regis Technologies
Morton Grove, Illinois, United States Regis Technologies is a contract development and manufacturing organization (CDMO) that offers a broad spectrum of services, including process research & development, analytical & stability, cGMP API manufacturing, CMC support, and a variety of chromatography products. Regis Technologies is based in Morton Grove, Illinois. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 127.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Ardian is a mega-sized diversified investment group focused on opportunities worldwide. Ardian invests across and manages funds focused on small and mid-sized buyouts, growth capital financings, mezzanine, infrastructure, real estate, and co-investment opportunities. Ardian's small-buyouts group targets controlling interests in French, German, and Italian businesses valued up to €100 million. It's mid-sized buyout group seeks businesses valued up €1.5 billion and does not have any geographic limitations. The Infrastructure team looks for European opportunities and can commit up to €1 billion per transaction. The Mezzanine group supports junior capital commitments of €5 to €80 million. In addition to direct investing, Ardian also manages various private equity fund-of-funds. Ardian was founded in 1996 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 176 of 247 |
| Sector: Life Science M&A | 5 of 8 |
| Type: Add-on Acquisition M&A Deals | 45 of 63 |
| Country: Germany M&A | 15 of 21 |
| Year: 2020 M&A | 2 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-01 |
Custom Solutions
France Custom Solutions specialized in sales promotion and e-logistics. The company's historical core business line is the management of promotional marketing for mass-market brands: payback, deferred bonuses and shops, quizzes and multimedia games. Custom Solutions also provides outsourcing services for POS-A (point of sale advertising) logistics and e-logistics. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-16 |
Frulact
Gemunde - Maia, Portugal Frulact is a producer of natural fruit-based and plant-based specialty ingredients for the Food & Beverage industry. The Group has a global presence across three continents, with nine business units in five countries (Portugal, Morocco, France, South Africa, and Canada). Frulact was founded in 1987 and is based in Gemunde - Maia, Portugal. |
Buy | - |
